Search Results - "Shawa, Imad"
-
1
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Published in The New England journal of medicine (21-01-2021)“…In a phase 2 trial, outpatients with Covid-19 who received a single infusion of a 2800-mg dose of the neutralizing antibody LY-CoV555 had a greater reduction…”
Get full text
Journal Article -
2
Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19
Published in Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (2022)“…BACKGROUND Severe cases of coronavirus disease 2019 (COVID-19) are characterized by progressive respiratory failure and the development of acute respiratory…”
Get full text
Journal Article -
3
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Published in JAMA : the journal of the American Medical Association (16-02-2021)“…IMPORTANCE: Coronavirus disease 2019 (COVID-19) continues to spread rapidly worldwide. Neutralizing antibodies are a potential treatment for COVID-19…”
Get full text
Journal Article -
4
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
Published in The lancet respiratory medicine (01-04-2022)“…The oral, selective Janus kinase 1/2 inhibitor baricitinib has shown efficacy in studies of hospitalised adults with COVID-19. COV-BARRIER (NCT04421027) was a…”
Get full text
Journal Article -
5
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load
Published in Clinical infectious diseases (24-08-2022)“…Abstract Background Based on interim analyses and modeling data, lower doses of bamlanivimab and etesevimab together (700/1400 mg) were investigated to…”
Get full text
Journal Article -
6
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT
Published in Circulation (New York, N.Y.) (01-11-2022)“…The efficacy and safety of prophylactic full-dose anticoagulation and antiplatelet therapy in critically ill COVID-19 patients remain uncertain. COVID-PACT…”
Get full text
Journal Article -
7
A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2
Published in Infectious diseases and therapy (01-12-2021)“…The severity of coronavirus disease 2019 (COVID-19) ranges from mild to death, with high morbidity and mortality rates reported amongst a vulnerable subset of…”
Get full text
Journal Article -
8
1027: WAKE ME UP BEFORE YOU GO GO: USING LEAN METHODOLOGY TO CHANGE CULTURE AND SEDATION MANAGEMENT
Published in Critical care medicine (01-01-2020)Get full text
Journal Article -
9
Pulmonogist led Eli Lilly's COVID-19 antibody trial at Franciscan
Published in Indianapolis Business Journal (17-09-2021)Get full text
Journal Article Trade Publication Article -
10
Erratum
Published in Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (01-12-2022)Get full text
Journal Article -
11
Erratum
Published in Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (13-12-2022)Get full text
Journal Article -
12
Erratum
Published in Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (01-01-2022)Get full text
Journal Article -
13
Erratum: Erratum
Published in Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (2022)“…[This corrects the article DOI: 10.1177/11795484221119316.]…”
Get full text
Journal Article -
14
Erratum
Published in Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (01-01-2022)Get full text
Journal Article -
15
Optimization of Pneumonia Treatment in an Intensive Care Unit Utilizing a Pharmacist-Driven Protocol
Published in Open forum infectious diseases (01-12-2016)Get full text
Journal Article